- Financial results and highlights for the first quarter ended January 31, 2021 on Wednesday March 31, 2021 after market close.
- Valeo will host a conference call to discuss those results and highlights on Thursday April 1, 2021 at 8.30am (ET) .
MONTREAL , March 26, 2021 – Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (” Valeo ” or the ” Company “), a Canadian pharmaceutical company, announced today that it will report its financial results and highlights for the first quarter ended January 31, 2021 on Wednesday March 31, 2021 after market close.
Valeo will host a conference call to discuss those results and highlights on Thursday April 1, 2021 at 8.30am (ET) . The telephone numbers to access the conference call are 1-888-231-8191 and 647-427-7450. An audio replay of the call will be available. The numbers to access the audio replay are 1-855-859-2056 and 416-849-0833 using the following access code (5555964).
A live audio webcast of the conference call will be available via: https://produceredition.webcasts.com/starthere.jsp?ei=1444812&tp_key=929d96e070
About Valeo Pharma
Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter .
Tags: BioSyent Inc., CSE, HLS Therapeutics, investment, Knight Therapeutics, Medexus Pharmaceuticals, pharma